Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
Rebecca Howell,1 Adrienne M Wright,1 Jennifer N Clements2 1Presbyterian College School of Pharmacy, Clinton, SC 29325, USA; 2Department of Pharmacy Practice, Presbyterian College School of Pharmacy, Clinton, SC 29325, USA Abstract: Metformin is the first-line therapy for the management of type 2 dia...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/418b5a932ce94726935dae48e2b6e826 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|